“…Particular interest to us, is the utilization of heterocyclic-derived ligands incorporating benz(imidazole/othiazole/oxazole) moieties due to their multitude of biological activities [3][4][5]. In addition, the secondary metabolite, chromone and its organic and inorganic compounds have proven to exhibit potent anticancer activities against a wide range of cancer cell lines [6][7][8][9]. Most recently, we have also designed Schiff bases containing the tetrahydro-2H-pyrane moiety which shares the same backbone structure as the sugar derivative, mannose.…”